Increasing Influenza Vaccination Rates in People With Chronic Illness.

Linda Sanftenberg, Felix Brombacher, J��rg Schelling, Stefanie J Klug, Jochen Gensichen
Author Information

Abstract

BACKGROUND: The safety and efficacy of influenza vaccination for the chronically ill are clearly supported by the evidence, yet vaccination rates in this vulnerable popu- lation remain low. This leads to many avoidable hospitalizations and deaths in Germany every year. The goal of this systematic review is to identify measures in primary care medicine that can be used to increase influenza vaccination rates among the chronically ill.
METHODS: This review was carried out as recommended in the PRISMA statement. A systematic literature search was performed. Only randomized, controlled trials were included in the analysis. Details can be found in the study protocol (PROSPERO, CRD42018114163).
RESULTS: 15 trials were included in the analysis. Training sessions for medical practice teams focusing on a particular disease raised the vaccination rates by as much as 22%. A financial incentive had the greatest effect (relative risk [RR]: 2.79; 95% confidence interval: [1.18; 6.62]). Reminders via text message yielded a maximum 3.8% absolute increase in vaccination rates. Complex interventions were not found to be of any greater benefit than simple ones.
CONCLUSION: A variety of approaches can be effective. Focusing training sessions for medical practice teams on certain diseases may be of greater benefit than vacci- nation-centered training sessions. Reminder systems for doctors should be more reliably implemented. Simple strategies are perhaps the most suitable ones in the heterogeneous population of chronically ill persons. The limitations of this system- atic review include the heterogeneity of the studies that we examined and the small number of studies in each category.

References

  1. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD003030 [PMID: 19370580]
  2. Dtsch Arztebl Int. 2019 Jun 10;116(23-24):413-419 [PMID: 31366435]
  3. Adv Exp Med Biol. 2017;968:19-34 [PMID: 28315129]
  4. J Emerg Med. 2009 Nov;37(4):439-43 [PMID: 19201131]
  5. J Med Internet Res. 2015 Feb 24;17(2):e52 [PMID: 25803266]
  6. Eur Heart J. 2004 Jan;25(1):25-31 [PMID: 14683739]
  7. Epidemiol Health. 2018;40:e2018034 [PMID: 30056640]
  8. J Gen Intern Med. 1992 Sep-Oct;7(5):535-7 [PMID: 1403212]
  9. Ann Fam Med. 2017 Nov;15(6):507-514 [PMID: 29133488]
  10. Stat Med. 2002 Jun 15;21(11):1539-58 [PMID: 12111919]
  11. Clin J Am Soc Nephrol. 2014 Sep 5;9(9):1526-35 [PMID: 25135764]
  12. J Gen Intern Med. 1998 Jul;13(7):469-75 [PMID: 9686713]
  13. Am J Manag Care. 2004 Oct;10(10):698-702 [PMID: 15521161]
  14. Health Serv Res. 2005 Apr;40(2):477-97 [PMID: 15762903]
  15. Vaccine. 2017 Nov 7;35(47):6367-6374 [PMID: 29031694]
  16. Fam Pract. 2016 Dec;33(6):663-670 [PMID: 27535327]
  17. BMJ. 2010 Mar 23;340:c332 [PMID: 20332509]
  18. Open Med. 2009;3(3):e123-30 [PMID: 21603045]
  19. BMJ. 2002 Oct 26;325(7370):938 [PMID: 12399344]
  20. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2019 Apr;62(4):433-439 [PMID: 30820616]
  21. Prev Med. 2012 Jul;55(1):72-7 [PMID: 22414740]
  22. Eval Health Prof. 2003 Sep;26(3):340-51 [PMID: 12971203]
  23. JAMA. 2002 Oct 16;288(15):1909-14 [PMID: 12377092]
  24. Dtsch Arztebl Int. 2017 Feb 10;114(6):87-93 [PMID: 28266301]
  25. Am J Public Health. 1987 May;77(5):626-7 [PMID: 3565663]
  26. BMC Public Health. 2015 Jul 07;15:618 [PMID: 26148480]
  27. Asian Pac J Allergy Immunol. 2015 Mar;33(1):3-7 [PMID: 25840627]
  28. Curr Med Res Opin. 2018 Jul;34(7):1201-1207 [PMID: 28918667]
  29. Acad Emerg Med. 2006 Sep;13(9):922-30 [PMID: 16902048]
  30. BMC Fam Pract. 2014 Aug 30;15:148 [PMID: 25175589]
  31. J Gen Intern Med. 2018 Jul;33(7):1142-1154 [PMID: 29728892]
  32. Am J Prev Med. 2017 Nov;53(5):680-688 [PMID: 28928039]
  33. Cochrane Database Syst Rev. 2014 Jul 07;(7):CD005188 [PMID: 24999919]
  34. J Am Geriatr Soc. 1997 May;45(5):543-9 [PMID: 9158573]
  35. J Gen Intern Med. 1994 Dec;9(12):679-83 [PMID: 7876950]
  36. Hum Vaccin Immunother. 2018 Mar 4;14(3):724-735 [PMID: 28481673]
  37. J Fam Pract. 1991 Nov;33(5):495-8 [PMID: 1940817]
  38. J Health Commun. 2015 Aug;20(8):920-9 [PMID: 26065492]
  39. East Mediterr Health J. 2017 Jun 14;23(4):303-310 [PMID: 28634981]
  40. Dtsch Arztebl Int. 2016 Nov 25;113(47):799-807 [PMID: 28043323]
  41. Diabetes Res Clin Pract. 2016 Oct;120:117-23 [PMID: 27541821]
  42. BMJ Open. 2016 Feb 19;6(2):e010069 [PMID: 26895984]
  43. J Gen Intern Med. 1992 Nov-Dec;7(6):623-9 [PMID: 1453246]
  44. HIV Med. 2017 Aug;18(7):500-506 [PMID: 28035738]
  45. BMC Med. 2014 Dec 19;12:244 [PMID: 25523432]
  46. Am J Med. 1996 Dec;101(6):612-20 [PMID: 9003108]
  47. Dtsch Arztebl Int. 2018 Oct 26;115(43):715-722 [PMID: 30518470]
  48. J Am Geriatr Soc. 2005 Jun;53(6):1008-10 [PMID: 15935025]
  49. Br J Gen Pract. 2002 Sep;52(482):735-40 [PMID: 12236277]
  50. Eur Respir J. 2018 May 10;51(5): [PMID: 29650559]
  51. J Am Board Fam Pract. 1991 Jan-Feb;4(1):19-26 [PMID: 1996510]
  52. BMC Pulm Med. 2017 May 3;17(1):79 [PMID: 28468650]
  53. Vaccine. 2014 Jul 31;32(35):4478-4484 [PMID: 24962759]
  54. Heart Fail Rev. 2017 May;22(3):329-336 [PMID: 28508293]
  55. Epidemiol Infect. 2016 Feb;144(3):537-47 [PMID: 26168005]

MeSH Term

Chronic Disease
Germany
Humans
Influenza Vaccines
Influenza, Human
Primary Health Care
Randomized Controlled Trials as Topic
Reminder Systems
Vaccination

Chemicals

Influenza Vaccines

Word Cloud

Created with Highcharts 10.0.0vaccinationrateschronicallyillreviewcansessionsinfluenzasystematicincreasetrialsincludedanalysisfoundmedicalpracticeteamsgreaterbenefitonestrainingstudiesBACKGROUND:safetyefficacyclearlysupportedevidenceyetvulnerablepopu-lationremainlowleadsmanyavoidablehospitalizationsdeathsGermanyeveryyeargoalidentifymeasuresprimarycaremedicineusedamongMETHODS:carriedrecommendedPRISMAstatementliteraturesearchperformedrandomizedcontrolledDetailsstudyprotocolPROSPEROCRD42018114163RESULTS:15Trainingfocusingparticulardiseaseraisedmuch22%financialincentivegreatesteffectrelativerisk[RR]:27995%confidenceinterval:[118662]Remindersviatextmessageyieldedmaximum38%absoluteComplexinterventionssimpleCONCLUSION:varietyapproacheseffectiveFocusingcertaindiseasesmayvacci-nation-centeredRemindersystemsdoctorsreliablyimplementedSimplestrategiesperhapssuitableheterogeneouspopulationpersonslimitationssystem-aticincludeheterogeneityexaminedsmallnumbercategoryIncreasingInfluenzaVaccinationRatesPeopleChronicIllness

Similar Articles

Cited By (7)